Top Industry Leaders in the Controlled Release Drug Delivery Market
Latest Controlled Release Drug Delivery Companies Update
Alkermes and Eli Lilly collaborate will co-develop and commercialize a long-acting injectable form of Eli Lilly's GLP-1 receptor agonist for diabetes management, leveraging Alkermes' expertise in CRDD technologies.
Johnson & Johnson expands its CRDD portfolio acquisition of Elan Drug Technologies further strengthens their presence in the market, adding Elan's innovative transdermal patches and other delivery systems.
Intract Pharma signs licensing agreement with Hikma deal allows Hikma to commercialize Intract's Duocet capsule technology, a novel approach for combining two drugs with different release profiles in a single dosage form.
List of Controlled Release Drug Delivery Key Companies in the Market
- Depomed, Inc. (US)
- Coating Place, Inc.(US)
- Corium International Inc.(US)
- Alza Corporation (Johnson & Johnson)(US)
- Pfizer Inc.(US)
- SKY Pharmaceuticals Pvt. Ltd.(China)
- AstraZeneca (US)
- Biogen (US)
- GlaxoSmithKline (UK)
- Novartis (UK)
- Allergan (Ireland)
- Collegium Pharmaceutical (US)